CRISPR Therapeutics outlines 2026 milestones with $2 billion cash
Go back to CRISPR Therapeutics outlines 2026 milestones with $2 billion cash| (NASDAQ: CRSP) | Delayed: 56.82 -0.16 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.98 | 52 Week High | $18.88 | |||
| Open | $56.22 | 52 Week Low | $13.75 | |||
| Day High | $57.13 | P/E | N/A | |||
| Day Low | $55.43 | EPS | $0.00 | |||
| Volume | 890,775 | |||||

